| SEQ_NO | 1 | Date of announcement | 2025/01/14 | Time of announcement | 16:35:35 |
| Subject | Medeon, on behalf of its subsidiary Medeologix Corporation, announces the resolution of BOD on the issuance of common shares. | ||||
| Date of events | 2025/01/14 | To which item it meets | paragraph 11 | ||
| Statement | 1.Date of the board of directors resolution:2025/01/14 2.Source of capital increase funds: Issuance of New Shares of common shares for Cash Capital Increase 3.Whether to adopt shelf registration (Yes, please state issuance period/No): No 4.Total monetary value of the issuance and number of shares issued (shares issued not including those distributed to employees if consisting in capital increase from earnings or capital surplus): Total monetary value of the issuance?GNT$224,000,000 Number of shares issued?Gcommon shares 8,960,000 shares 5.If adopting shelf registration, monetary value and number of shares to be issued this time: NA 6.The remaining monetary value and shares after this issuance when adopting shelf registration: NA 7.Par value per share: NT$10 8.Issue price: NT$25 9.Number of shares subscribed for by or allocated to employees: 10% of the total issued shares, amounting to 896,000 shares, are reserved for subscription by the Medeologix Corporation’s employees. 10.Number of shares publicly sold: NA 11.Ratio of shares subscribed by or allotted as stock dividends to existing shareholders: The remaining number of shares to be issued will be subscribed in proportion to the shareholders and their shareholdings as recorded in the shareholders’ register on the basis of the subscription date. 12.Handling method for fractional shares and shares unsubscripted for by the deadline: Shares renounced by original shareholders and employees, or fractional shares that are less than one share, are authorized to be subscribed by the Chairman of the Board of Directors through a specific person at the issue price. 13.Rights and obligations of these newly issued shares: The rights and obligations of the new shares issued in this cash capital increase are identical to those of the originally issued common shares. 14.Utilization of the funds from the capital increase: To increase working capita 15.Any other matters that need to be specified:None |
||||